Recipharm, the contract development and manufacturing organisation (CDMO), has entered into a long term agreement with Sato Pharmaceutical Co. for...
Read more
BioSig Technologies, Inc , a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an...
Read more
Jazz Pharmaceuticals plc announced that the first patient has been enrolled in a Phase 3 clinical study evaluating JZP-258, an...
Read more
Catalyst Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare neuromuscular and...
Read more
EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the US and Canada, and Pfizer Inc. announced that...
Read more
PMV Pharmaceuticals, Inc., a leader in the discovery and development of p53-targeted small molecule drugs for the treatment of cancer...
Read more
Apitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, announces positive results from...
Read more
CohBar Inc , a preclinical stage biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced...
Read more
Vifor Pharma, a company of the Galenica Group, and ChemoCentryx, Inc. announced that Vifor Pharma has gained rights to commercialize...
Read more
Eli Lilly and Company and Incyte Corporation announced that the EC has granted marketing authorisation for Olumiant® (baricitinib) 4 mg...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
